What does Average Directional Index Predict about Heron Therapeutics, Inc. (NASDAQ:HRTX)?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Heron Therapeutics, Inc. (NASDAQ:HRTX) for the period of 9-Day stands at 63.46% while the stochastic %D for the same period stands at 74.63%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Heron Therapeutics, Inc. (NASDAQ:HRTX) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Heron Therapeutics, Inc. (NASDAQ:HRTX) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Heron Therapeutics, Inc. (NASDAQ:HRTX)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY   CA.

Previous Day Activity Analysis

On the last trading day, Heron Therapeutics, Inc. (NASDAQ:HRTX) opened the session at $15.9 and after going down -3.36% closed at $15.8. The stock lost -0.1 points in the last trade.

Heron Therapeutics, Inc. (NASDAQ:HRTX)’s stock fluctuated in the range of $15.45 and $16.15 during the previous active session. Heron Therapeutics, Inc. (NASDAQ:HRTX) traded with the volume of 883410 with average volume of 707.85 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 2.06 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.85 and 49.9 respectively.

Currently the Insider Ownership of the shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) is at 0.18% and the shares outstanding are 57.84 Million.

Important Ratio Analysis

Some important ratios to consider here for Heron Therapeutics, Inc. (NASDAQ:HRTX) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 41.54 and 21.35 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 12.35 and 0 correspondingly.

The Quick Ratio of Heron Therapeutics, Inc. (NASDAQ:HRTX) stands at 2 while the Current Ratio depicts the value of 2.1.

Return on Assets ROA of Heron Therapeutics, Inc. (NASDAQ:HRTX) is at -141.4% whereas, Return on Equity ROE and Return of Investment ROI of Heron Therapeutics, Inc. (NASDAQ:HRTX) stand at -385.1% and -540.9% respectively.

Stock Performance Analysis

The stock performance of Heron Therapeutics, Inc. (NASDAQ:HRTX) on the basis of 5 day trade show the dip of -1.56% whereas, the monthly performance of the stock shows increase of 2.6%.

The quarterly performance of the stock remained in green zone with the value of 2.6% while six month performance of the shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) remained bullish with the count of 10.49%.

The yearly and YTD performance of Heron Therapeutics, Inc. (NASDAQ:HRTX) remained mix at -16.84% and 20.61% respectively.